HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peter Dreger Selected Research

Cytokine Release Syndrome

1/2024Management of Patients Undergoing CAR-T Cell Therapy in Germany.
10/2023Idecabtagene Vicleucel Is Well Tolerated and Effective in Relapsed/Refractory Myeloma Patients with Prior Allogeneic Stem Cell Transplantation.
1/2022EASIX and Severe Endothelial Complications After CD19-Directed CAR-T Cell Therapy-A Cohort Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Peter Dreger Research Topics

Disease

48B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2023 - 03/2003
47Neoplasms (Cancer)
05/2024 - 06/2003
37Lymphoma (Lymphomas)
01/2024 - 06/2003
29Graft vs Host Disease (Graft-Versus-Host Disease)
03/2024 - 09/2006
21Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 06/2003
18Leukemia
03/2024 - 10/2004
18B-Cell Lymphoma (Lymphoma, B Cell)
01/2024 - 12/2015
17Hematologic Neoplasms (Hematological Malignancy)
05/2024 - 06/2003
12Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2024 - 01/2009
12Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2021 - 01/2009
10Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2024 - 10/2015
10Multiple Myeloma
01/2024 - 06/2006
10Residual Neoplasm
01/2023 - 10/2004
10Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2021 - 03/2006
8Primary Myelofibrosis (Myelosclerosis)
05/2024 - 04/2009
8Infections
05/2024 - 06/2014
7Hodgkin Disease (Hodgkin's Disease)
11/2020 - 04/2004
5COVID-19
05/2024 - 10/2020
5Disease Progression
10/2022 - 06/2018
4T-Cell Lymphoma (Lymphoma, T Cell)
01/2023 - 06/2014
4Bronchiolitis Obliterans Syndrome
10/2021 - 01/2012
4Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2021 - 10/2016
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 12/2008
3Cytokine Release Syndrome
01/2024 - 01/2022
3Weight Loss (Weight Reduction)
02/2022 - 05/2015
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2019 - 01/2008
2Immunoglobulin Light-chain Amyloidosis
10/2023 - 01/2016
2cell-associated neurotoxicity
10/2023 - 01/2022
2Cytopenia
01/2023 - 01/2020
2Inflammation (Inflammations)
01/2023 - 12/2020
2Sepsis (Septicemia)
01/2022 - 10/2013
2Pathologic Complete Response
11/2019 - 04/2004
2Aplastic Anemia (Anemia, Hypoplastic)
06/2019 - 01/2019
2Thrombotic Microangiopathies
10/2018 - 09/2017
2Fatigue
10/2016 - 09/2015
2Amyloidosis
01/2016 - 03/2009
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2014 - 06/2014
2Thrombocytosis (Thrombocythemia)
07/2012 - 12/2009
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
06/2010 - 05/2007
1Persistent Infection
05/2024
1Esophageal Neoplasms (Esophageal Cancer)
05/2024
1Autoimmune Diseases (Autoimmune Disease)
05/2024
1Hypertension (High Blood Pressure)
03/2024
1Cardiotoxicity
03/2024
1Cardiovascular Diseases (Cardiovascular Disease)
03/2024
1Neurotoxicity Syndromes (Toxic Encephalopathy)
01/2024
1Systemic Scleroderma (Systemic Sclerosis)
12/2023

Drug/Important Bio-Agent (IBA)

29Chimeric Antigen ReceptorsIBA
01/2024 - 10/2016
12Rituximab (Mabthera)FDA Link
01/2021 - 01/2007
10Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2024 - 01/2012
10SteroidsIBA
01/2022 - 08/2011
8fludarabineIBA
02/2024 - 04/2004
6Busulfan (Busulfex)FDA Link
05/2024 - 12/2009
5treosulfanIBA
05/2024 - 01/2020
5Biomarkers (Surrogate Marker)IBA
03/2024 - 03/2014
5ibrutinibIBA
01/2023 - 01/2019
5Proteins (Proteins, Gene)FDA Link
10/2022 - 06/2003
5idelalisibIBA
02/2022 - 01/2019
4axicabtagene ciloleucelIBA
01/2024 - 10/2021
4Cytarabine (Cytosar-U)FDA LinkGeneric
01/2021 - 08/2014
3AntigensIBA
03/2024 - 06/2006
3venetoclaxIBA
01/2023 - 01/2020
3obinutuzumabIBA
01/2023 - 01/2022
3purineIBA
11/2019 - 12/2014
3Brentuximab VedotinIBA
01/2019 - 11/2012
2B-Cell Maturation AntigenIBA
10/2023 - 10/2020
2AntibodiesIBA
10/2022 - 10/2020
2LeptinIBA
02/2022 - 05/2015
2CytokinesIBA
10/2021 - 12/2020
2Etoposide (VP 16)FDA LinkGeneric
01/2021 - 12/2018
2PlatinumIBA
01/2021 - 04/2018
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
10/2018 - 03/2014
2serum P-component (CIt)IBA
06/2018 - 01/2018
2Vitamin DFDA LinkGeneric
09/2017 - 01/2017
2Azacitidine (5 Azacytidine)FDA Link
01/2017 - 08/2014
2ThrombomodulinIBA
10/2014 - 11/2012
2Alemtuzumab (Campath)FDA Link
08/2009 - 09/2006
2Peptides (Polypeptides)IBA
06/2006 - 06/2003
2Immunoglobulins (Immunoglobulin)IBA
10/2004 - 03/2003
1Antiviral Agents (Antivirals)IBA
05/2024
1Immune Checkpoint InhibitorsIBA
05/2024
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
01/2024
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
01/2024
1Immunoglobulin G (IgG)IBA
01/2024
1Calcineurin InhibitorsIBA
01/2024
1Immunoglobulin M (IgM)IBA
10/2023

Therapy/Procedure

100Stem Cell Transplantation
05/2024 - 03/2003
52Therapeutics
05/2024 - 04/2004
41Transplantation
03/2024 - 04/2004
37Cell Transplantation
03/2024 - 01/2008
27Hematopoietic Stem Cell Transplantation
03/2024 - 11/2008
17Drug Therapy (Chemotherapy)
03/2024 - 04/2004
9Immunotherapy
01/2023 - 06/2018
9Homologous Transplantation
02/2022 - 11/2007
5Salvage Therapy
12/2023 - 06/2010
5Autologous Transplantation
05/2019 - 04/2004
4Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023 - 01/2012
3Photopheresis
01/2022 - 01/2018
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2019 - 01/2016
2Haploidentical Transplantation
01/2019 - 10/2017